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Wilson’s disease is an autosomal recessive disorder affecting copper transport; it results in the accumulation of copper 
in the liver, brain, and other organs. Wilson’s disease is the most common inherited liver disease with more than 500 
cases reported in Korea. An impairment in biliary excretion process leads to copper accumulation in the liver, which 
progressively damages the liver, leading to cirrhosis. Since effective treatment is available for this disease, early and correct 
diagnosis is very important. Here, we report a case of Wilson’s disease with mildly elevated liver enzyme levels in a 29-year-
old breast-feeding woman with weight loss.
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can lead to cirrhosis.
1) Chronic hepatitis often leads to nonspecific 
symptoms such as malaise, fatigue, and weakness, or no symptoms 
at all. It is commonly identi￿ed by blood tests performed either for 
screening or for evaluating nonspeci￿c symptoms. Hepatitis B and C 
are the most common causes of chronic hepatitis.
2,3) Drug-induced, 
alcoholic, and autoimmune hepatitis are other common causes of 
chronic hepatitis. In many cases, physicians can correctly diagnose 
the condition underlying by using clinical and laboratory findings. 
In some cases, physicians may misdiagnose, because they do not 
consider the hidden causes of chronic hepatitis.
Wilson's disease (WD), a genetic disorder involving biliary 
copper excretion, can cause elevated liver enzyme levels, lasting 
for more than 6 months in asymptomatic patients.
4,5) While the 
prevalence of WD is very low, it is a treatable liver disease and 
therefore needs to be properly identified.
6) Here, we report a case 
of WD with mildly elevated liver enzymes in a 29-year-old breast-
feeding woman with weight loss.
INTRODUCTION
Chronic hepatitis is defined as an inflammatory disease of the 
liver lasting for more than 6 months. Mild forms of the liver disease 
are non-progressive or show slow progression, whereas other more 
severe forms are associated with architectural disorganization, which Young-Hye Cho, et al: A Case of Wilson's Disease in Patient with Mildly Elevated Liver Enzymes
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normal. Liver enzyme assay revealed the levels of AST, ALT, ALP, 
and total bilirubin to be 52 U/L, 55 U/L, 323 IU/L, and 0.6 mg/dL. 
We, therefore, checked for anti-HAV IgM, HBsAg, anti-HBc IgM, 
and anti-HCV antibodies, but the results were negative. She had 
no history of any medicines or herbs. Thyroid function test, chest 
X-ray, and gastrofiberscopy showed no abnormalities. Abdominal 
ultrasonography revealed no remarkable ￿ndings except for a small 
hepatic cyst. 
We advised her to increase her food intake. Next, we planned 
to recheck liver function tests on the basis of the elevated levels of 
liver enzymes. A￿er 1 week, she had gained about 1 kg and showed 
improvement in subjective health status. ￿e levels of liver enzymes 
had decreased, i.e., AST level decreased to 46 U/L and ALT, to 52 U/
L. ￿erefore, we planned to monitor her progress.
A￿er 1 month, her weight remained unchanged at 42.7 kg. Her 
AST level increased to 56 U/L, and ALT level, 72 U/L (Table 1). 
Further examination for chronic hepatitis was conducted. Her serum 
ceruloplasmin level had reduced to 4 mg/dL (normal, 17.9 to 53.3 
mg/dL), and copper level had reduced to 59.2 μg/dL (normal, 75 
to 145 μg/dL), whereas after 24 hours, the rate of urinary copper 
excretion increased to 291.5 μg/day (normal, 15 to 60 μg/day). 
Ophthalmological examination did not show the presence of Kayser-
Fleischer ring.
We performed ultrasound-assisted percutaneous liver biopsy. 
The liver copper content was slightly elevated at 45.68 μg/g 
dry weight (normal, 10 to 35 μg/g). We proceeded to perform 
mutation analysis of the ATP7B gene. Upon sequencing, we 
detected compound heterozygosity for c.2621C>T (p.A874V) 
and c.3877G>A (E1293K) (Table 2). ￿e c.2621C>T (p.A874V) 
mutation is the most commonly detected mutation in WD. Trientine 
therapy was initiated (250 mg, four times/day). At a follow-up 7 
months later, her liver enzyme level was normalized (AST 29 U/
L, ALT 35 U/L, ALP 212 U/L). At present she is on a maintenance 
CASE REPORT
 A 29-year-old breast-feeding mother was admitted to our 
hospital with a weight loss of approximately 20 kg during the 
preceding 8 months. She weighed 53 kg before pregnancy and 
gained 10 kg during pregnancy; this totaled to 63 kg. She lost 20 
kg within 8 months of delivery but complained of fatigue. Her 
appetite was good but she told us that she did not have enough time 
to eat. She was a non-smoker and non-drinker. She had no history 
of medical treatment, except for hepatotonic administration for 3 
months because she had elevated liver enzyme level. Family history 
did not yield any remarkable ￿ndings. On physical examination, the 
patient’s blood pressure was 96/60 mmHg; pulse, 76 beats/minute; 
temperature, 37
oC; and respiratory rate, 16 breaths/minute. Her 
weight was 42.2 kg, and her body mass index was 15.8 kg/m
2. Her 
tongue and skin showed no signs of dehydration. Auscultation of the 
heart and lung were normal, and the abdomen was so￿. Neurological 
examination yielded normal ￿ndings.
A normal hemogram was obtained during further examination. 
￿e levels of serum electrolytes, blood sugar, and creatinine were also 
Table 1. Disease course in this case.
Laboratory 
parameters
Before treatment After treatment
1st day 7th day 35th day 4 mo 7 mo
AST (IU/L)   52   46   56   54   29
ALT (IU/L)   55   52   72   69   35
ALP (IU/L) 323 333 329 240 212
Bilirubin (mg/dL)
     Total 0.6 0.7 0.8 0.4 0.4
     Direct 0.22 0.23 0.22 0.14 0.13
Table 2. ATP7B gene mutation in this case.
Exon Nucleotide Base change Codon Amino acid change Designation Mutation type
10 2495 A>G    832 Lys>Arg K832R Polymorphism
11 2621 C>T    874 Ala>Val A874V Mutation 
16 3419 T>C 1141 Val>Ala V1140A Polymorphism
18 3877 G>A 1293 Gla>Lys E1293K Mutation 
18 3889 G>A 1297 Val>Ile V1297I PolymorphismYoung-Hye Cho, et al: A Case of Wilson's Disease in Patient with Mildly Elevated Liver Enzymes
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dose of 750 mg (250 mg, three times/day).
DISCUSSION
 WD is an autosomal recessive disorder caused by mutation 
in the ATPB7 gene, which encodes a membrane-bound copper-
transporting ATPase. An impairment in biliary excretion leads to the 
accumulation of copper, initially in the liver, and then in the other 
tissues.
7,8) ￿e domestic frequency of WD is approximately 1 case in 
94,000 individuals in most populations, and approximately 1 case in 
156,000 individuals in populations older than 15 years of age.
6) Most 
patients present in their mid to late teenage years, although the age of 
presentation is quite broad and extends into the ￿￿h decade of life.
There is no single specific test for the diagnosis of WD. In a 
nation-wide survey of WD, low serum ceruloplasmin (<20 mg/dL), 
high 24-h urine copper level (>100 g), high hepatic copper content 
(>250 μg/g of dry liver), and Kayser–Fleischer rings were found in 
96%, 86%, 88%, and 73% cases, respectively.
6) A combination of any 
2 of the above 4 laboratory ￿ndings forms a strong support for the 
diagnosis of WD.
9-13) Genetic testing to confirm the diagnosis is a 
reasonable option, although a speci￿c mutation cannot be identi￿ed 
in all patients. Recently, a scoring system based on the clinical and 
biochemical parameters for the diagnosis of WD was proposed at 
the eighth International Conference on Wilson Disease and Menkes 
Disease (Table 3). In this case, she had a diagnostic score of 7 (Table 
3, shown in bold). 
Episodes of hepatitis can occur with elevated liver enzymes, 
and then, show spontaneous regression. WD leads to liver cirrhosis 
without adequate therapy. Hepatitis o￿en reoccurs, and most of these 
patients eventually develop cirrhosis.
14) In a study of 439 patients in 
Korea, 75% of the adult WD patients with hepatitis were diagnosed 
with liver cirrhosis because of delayed diagnosis. The neurological 
manifestations of WD typically occur in patients in their early 
Table 3. Scoring system developed at the 8th International Meeting on Wilson Disease, Leipzig, 2001.
Typical clinical symptom and signs Other tests
Kayer-Flesicher rings Liver copper ( in absence of cholestasis)
    Present             2    >250 μg/g                                 2
    Absent*            0    50-250 μg/g                                1
Neurologic symptom (or typical brain MRI)    Normal (<50 μg/g)*                             -1
   Present        2    Rhodamine-positive hepatocyte on biopsy  1
   Absent*        0 Urinary copper (in absence of acute hepatitis)
Serum ceruloplasmin    Normal                                      0
  Normal (>0.2 g/L)  0    1-2 × ULN 1
  0.1-0.2 g/L 1    >2 × ULN* 2
  <0.1 g/L* 2    Normal, but >5 × ULN after D-penicillamine 2
Coombs-negative hemolytic anemia Mutation analysis
   Present       1   Two chromosome mutations*                 4
   Absent*        0    One chromosome mutation                  1
   No mutations detected                      0
Total score                Evaluation 
  ≥ 4*                       Diagnosis highly likely
  2-3                           Diagnosis probable, more tests needed
  ≤1                               Diagnosis very unlikely
ULN: upper limit of normal range. 
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twenties. Neurological symptoms such as dystonia, incoordination, 
and tremor have been observed along with psychiatric symptoms 
such as depression, hyperactivity, or loss of sexual inhibition.
15)
In symptomatic WD patients, chelation therapy is an effective 
treatment strategy, wherein D-penicillamine and trientine were the 
most commonly used drugs. Patients are informed to avoid copper-
rich nutrients such as shell￿sh, organ meats, nuts, and chocolate.
16-18)
In the present case, it was difficult to make an early diagnosis, 
because even with a history of increased liver enzyme levels, more 
precise examinations were not prescribed, and the patient was 
prescribed hepatotonics in the local clinic. This patient did not 
have any other complications except hepatitis. Although her main 
complaint was weight loss during breast feeding, her enzyme 
levels were elevated, and we diagnosed WD by using the results of 
additional tests. We suggest that she lost her weight due to breast 
feeding and di￿culty in childcare. 
In many cases, if the ￿ndings of viral hepatitis tests are normal, 
we prescribe conservative treatment for patients with increased 
liver enzyme levels, because of the high frequency of viral- and 
alcohol-induced hepatitis in the Korean population. However, if the 
blood level of liver enzymes is consistently higher than the upper 
normal limit, further tests are necessary. WD can occur at various 
ages; therefore, early diagnosis and treatment are very important. 
Diagnosis may include procedures. WD patients lead healthy lives 
if they undergo proper treatment in the early stages of the disease. 
Therefore, it is imperative that the first physician does not fail to 
diagnose WD.
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